Q3 2025 Holdings
Filed 2025-11-14 | 62 holdings | $1.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc(NTRA) | COM | 632307104 | $249.5M | 1,550,280 | 13.6% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $139.0M | 1,252,312 | 7.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $81.2M | 2,793,987 | 4.4% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $79.9M | 190,626 | 4.4% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $77.6M | 588,828 | 4.2% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $63.2M | 823,933 | 3.5% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $57.8M | 1,947,579 | 3.2% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $55.6M | 569,427 | 3.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $52.5M | 779,616 | 2.9% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $49.6M | 110,896 | 2.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $47.8M | 393,499 | 2.6% |
| Roivant Sciences Ltd(ROIV) | SHS | G76279101 | $47.6M | 3,149,270 | 2.6% |
| iShares TR(IBB)Put | ISHARES BIOTECH | 464287556 | $46.9M | 325,000 | 2.6% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $46.2M | 117,875 | 2.5% |
| BridgeBio Pharma Inc(BBIO) | COM | 10806X102 | $43.2M | 831,847 | 2.4% |
| United Therapeutics Corp(UTHR)Put | COM | 91307C102 | $40.7M | 97,100 | 2.2% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $40.1M | 400,000 | 2.2% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $38.2M | 875,925 | 2.1% |
| AbbVie Inc(ABBV) | COM | 00287Y109 | $35.0M | 150,966 | 1.9% |
| Arrivent BioPharma Inc(AVBP) | COM | 04272N102 | $31.3M | 1,696,752 | 1.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $30.6M | 2,127,941 | 1.7% |
| Uniqure NV(QURE)Put | SHS | N90064101 | $29.2M | 500,000 | 1.6% |
| Glaukos Corp(GKOS) | COM | 377322102 | $25.5M | 312,994 | 1.4% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $25.1M | 922,695 | 1.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $24.9M | 246,966 | 1.4% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $22.5M | 473,625 | 1.2% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $22.5M | 565,417 | 1.2% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $20.0M | 365,000 | 1.1% |
| Immatics N.v(IMTX) | SHS | N44445109 | $19.0M | 2,227,837 | 1.0% |
| Summit Therapeutics Inc(SMMT)Call | COM | 86627T108 | $18.6M | 900,000 | 1.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $18.5M | 739,876 | 1.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $18.0M | 377,066 | 1.0% |
| Uniqure NV(QURE)Call | SHS | N90064101 | $17.5M | 300,000 | 1.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $16.6M | 1,222,263 | 0.9% |
| Merus N V | COM | N5749R100 | $15.7M | 166,729 | 0.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $15.0M | 104,339 | 0.8% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $14.8M | 440,092 | 0.8% |
| BioAge Labs Inc(BIOA) | COM | 09077V100 | $13.5M | 2,293,788 | 0.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $12.5M | 253,375 | 0.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $12.5M | 985,828 | 0.7% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $11.5M | 186,932 | 0.6% |
| GE Healthcare Technologies Inc(GEHC) | COM | 36266G107 | $11.3M | 151,085 | 0.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $11.2M | 166,281 | 0.6% |
| Praxis Precision Medicines Inc(PRAX) | COM | 74006W207 | $9.2M | 172,833 | 0.5% |
| Savara Inc(SVRA) | COM | 805111101 | $8.7M | 2,427,724 | 0.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $8.4M | 520,240 | 0.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $8.0M | 136,862 | 0.4% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $7.8M | 254,268 | 0.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $7.1M | 2,028,886 | 0.4% |
| Nektar Therapeutics(NKTR) | COM | 640268306 | $6.7M | 118,419 | 0.4% |